Ardelyx reported $-32.79M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Amgen USD 3.83B 130M Mar/2026
Ardelyx USD -32.79M 37.89M Mar/2026
aTyr Pharma USD -128K 24.6M Mar/2026
Corcept Therapeutics USD -49.6M 54.09M Mar/2026
Curis USD -7.88M 4.63M Dec/2025
Sanofi EUR 2.27B 771M Mar/2026
TG Therapeutics USD 34.8M 15.7M Mar/2026
United Therapeutics USD 325.8M 340.4M Mar/2026